Vertebroplasty for the Treatment of Fractures Due to Osteoporosis

PHASE3CompletedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

August 31, 2009

Study Completion Date

September 30, 2009

Conditions
Spinal FracturesOsteoporosis
Interventions
DEVICE

Percutaneous vertebroplasty

Placement of polymethylmethacrylate (PMMA) into vertebral compression fracture

PROCEDURE

Sham vertebroplasty

Participants, following local anesthesia with lidocaine and bupivacaine, were given verbal and physical cues such as pressure on the back, but the needle was not placed.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

collaborator

National Center for Research Resources (NCRR)

NIH

lead

Mayo Clinic

OTHER

NCT00068822 - Vertebroplasty for the Treatment of Fractures Due to Osteoporosis | Biotech Hunter | Biotech Hunter